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Abstract Glucosylceramides (GlcCer) were extracted from the
plant pathogen Colletotrichum gloeosporioides and puri¢ed by
several chromatographic steps. By using electrospray ionization
mass spectrometry and nuclear magnetic resonance, GlcCer
from C. gloeosporioides were identi¢ed as N-2P-hydroxyocta-
decanoyl-1-L-D-glucopyranosyl-9-methyl-4,8-sphingadienine and
N-2P-hydroxyoctadecenoyl-1-L-D-glucopyranosyl-9-methyl-4,8-
sphingadienine. Monoclonal antibodies against these structures
were produced and used as tools for the evaluation of the role of
GlcCer in the morphological transition of C. gloeosporioides. In
the presence of antibodies to GlcCer, the di¡erentiation of con-
idia into mycelia was blocked. Since GlcCer is present in several
plant pathogens, the inhibitory activity of external ligands rec-
ognizing these structures may be applicable in other models of
fungal infections.
- 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Colletotrichum is a large genus of ascomycete fungi that
comprises several plant pathogens. Plant diseases caused by
Colletotrichum species include anthracnose or blight on a wide
range of important crop and ornamental plants [1,2]. The
control of anthracnose has become increasingly complex be-
cause of the recent appearance of isolates resistant to chemical
fungicides [1]. In this context, the search for new strategies to
inhibit the colonization of plant hosts by Colletotrichum spe-
cies is imperative. The need of new antifungal agents e¡ective
against members of the genus Colletotrichum is supported by
their recent identi¢cation as the causing agents of phaeohy-
phomycosis in human hosts [3].
The infection by Colletotrichum species includes stages of
spore adhesion and germination, formation of germ tube and
appressorium, and development of biotrophic and necrotro-
phic hyphae [2]. Therefore, the understanding of the process
of di¡erentiation by molecular, biochemical, and immunolog-
ical approaches may reveal the existence of new targets to be
used in the inhibition of fungal morphogenesis and, conse-
quently, establishment of infection.
Fungal cerebrosides are apparently involved with morpho-
genesis in several human and plant pathogens [4]. They are
composed of a sugar unit, usually glucose or galactose, bound
to a hydrophobic ceramide, containing the conserved sphin-
gobase 9-methyl-4,8-sphingadienine in amidic linkage to 2-hy-
droxyoctadecanoic or 2-hydroxyhexadecanoic acids [4^14].
For that reason, they are also called glycosylceramides or
ceramide monohexosides. The involvement of glycosylcera-
mides with fungal di¡erentiation was ¢rst reported by Kawai
and coworkers [15,16], who demonstrated that these molecules
had fruiting-inducing activity in bioassays with Schizophyllum
commune. The intact 9-methyl-4,8-sphingadienine but not the
L-glucopyranosyl residue was essential for this activity. The
involvement of cerebrosides in fungal growth was further con-
¢rmed by experiments using a family of compounds known to
inhibit GlcCer synthase in mammals. Two analogs, D-threo-1-
phenyl-2-palmitoyl-3-pyrrolidinopropanol (P4) and D-threo-
3P,4P-ethylenedioxy-P4, strongly inhibited germination and
hyphal growth of Aspergillus nidulans and Aspergillus fumiga-
tus [17].
Antibodies to cerebrosides have also been recently used as
inhibitory tools of the morphological transitions of fungal
species. We have demonstrated that the binding of polyclonal
anti-GlcCer antibodies to the fungal cell surface inhibits bud
formation in Cryptococcus neoformans [11], and germ tube
formation in Pseudallescheria boydii and Candida albicans
[10]. In the present work, we report on the characterization
of cerebrosides in Colletotrichum gloeosporioides. They are
glucosylceramides (GlcCer) containing 9-methyl-4,8-sphinga-
dienine in amidic linkage to 2-hydroxyoctadecanoic or 2-hy-
droxyoctadecenoic acids, as demonstrated by electrospray ion-
ization mass spectrometry (ESI-MS) and nuclear magnetic
resonance (NMR). Polyclonal and monoclonal antibodies to
GlcCer were generated and used in di¡erentiation assays of
C. gloeosporioides, demonstrating that binding of anti-GlcCer
antibodies to the fungal surface results in the inhibition of the
morphological transition of conidia to mycelia. These results
suggest that external ligands recognizing GlcCer can inhibit
fungal morphogenesis, which could be also applicable in plant
pathogens expressing similar GlcCer [6,8,18^20].
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2. Materials and methods
2.1. Microorganism
C. gloeosporioides was kindly supplied by Prof. Rosalie R.R. Coel-
ho from the Soil Laboratory, Departamento de Microbiologia Geral,
Instituto de Microbiologia, UFRJ, Rio de Janeiro, RJ, Brazil. Myce-
lial cells were cultivated at room temperature in Sabouraud’s modi¢ed
liquid medium, containing (g/l) 20 glucose, 10 peptone and 5 yeast
extract. After 7 days of growth, fungal cells were obtained by ¢ltra-
tion, washed three times with distilled water and stored at 320‡C.
Conidial forms of C. gloeosporioides were grown on malt agar plates
containing (g/l) 4 glucose, 4.5 yeast extract, 10 malt extract, 20 agar,
at room temperature for 7 days. After this period, a preparation of
conidial cells was obtained by washing plate surface with phosphate-
bu¡ered saline (PBS). Cells were then washed three times with PBS
and counted in a Neubauer chamber.
2.2. Extraction and puri¢cation of GlcCer
C. gloeosporioides cells were successively extracted at 28‡C with
chloroform/methanol 2:1 and 1:2 (v/v). Extracts were combined, dried
and the crude lipid extract was partitioned according to Folch and
coworkers [21]. The lipids recovered from the Folch lower phase were
fractionated on a silica gel column eluted with chloroform, acetone
and then methanol. The glycolipid fraction eluted with acetone was
puri¢ed by further silica gel column chromatography. This column
was eluted sequentially with chloroform/methanol (95:5, 9:1, 8:2,
7:3 and 1:1, v/v) and ¢nally methanol. Fractions of 5 ml were
collected and analyzed by high-performance thin layer chromatogra-
phy (HPTLC), developed with chloroform/methanol/water 65:25:4
(v/v). The spots were visualized with iodine and by spraying with
orcinol/H2SO4. The chloroform/methanol 7:3 (v/v) fraction was fur-
ther puri¢ed by chromatography on Iatrobeads RS 2060 (Macherey
pNagel, Du«ren, Germany), using the same elution system, yielding a
partially puri¢ed glycosphingolipid fraction. Final puri¢cation
was attained after passage through a second Iatrobeads column
eluted with chloroform/methanol mixtures (9:1, 85:15, 8:2, 75:25,
and 1:1, v/v) and ¢nally methanol. The 8:2 chloroform/methanol
fraction contained the ¢nally puri¢ed glycolipid, as visualized by
HPTLC.
2.3. Sugar analysis
Glycosphingolipids were hydrolyzed with 3 M tri£uoroacetic acid at
100‡C for 3 h, and the resulting monosaccharides were characterized
by TLC and quanti¢ed by gas chromatography (GC) as alditol-ace-
tate derivatives [22] using an OV^225 fused silica capillary column
(30 mU0.25 mm internal diameter), with temperature programmed
from 50 to 220‡C at 50‡C/min.
2.4. ESI-MS analysis
Glycolipids were analyzed by ESI-MS using an LCQ-Duo ion trap
instrument (Finnigan Thermoquest, San Jose, CA, USA). Samples
were diluted in chloroform:methanol (1:1, v/v), containing either 10
mM ammonium acetate, 1% ammonium hydroxide or 10 mM lithium
iodide, and introduced into ESI-MS at 5^10 Wl/min £ow rate, with the
assistance of an infusion micropump (Harvard Apparatus, Cam-
bridge, MA, USA). Alternatively, samples were delivered (at 10^20
Wl/min) to the ion source through the mass spectrometer-embedded
valve loop using a solvent delivery system, pressurized with 9^10 psi
N2. Analyses were carried out at both positive (ESI+) and negative
(ESI3) ion modes. Source and capillary voltages were 4.5 kV and 3 V
(ESI+), or 34.5 kV and 339 V (ESI3). Capillary temperature was
kept at 200‡C for both ion modes. Spectra were collected at 200^2000
m/z range. Source-induced dissociation (SID) was obtained at 25 V.
Ion trap collision-induced dissociation (tandem ESI-MS/MS or ESI-
MS/MS) experiments were carried out at 20^40% (1^2 eV) energy. All
spectra were processed using the Xcalibur software (Finnigan Ther-
moquest).
2.5. 1H-NMR
A sample of GlcCer was dissolved in 0.5 ml CDCl3^CD3OD (2:1 v/
v) (99.9%; Merck, Darmstadt, Germany). The 1H-NMR spectrum
was acquired at 400 MHz using a Bruker Advance 400 spectrometer,
at a probe temperature of 303 K and a sweep width of 6127 Hz with
64K points.
2.6. Monoclonal antibodies to GlcCer
A puri¢ed GlcCer fraction (50 Wg) was resolved by TLC on a silica
plate. The puri¢ed cerebroside was scraped from the plate and, to-
gether with the silica, was suspended in phosphate bu¡er (pH 7.2),
followed by sonication and emulsi¢cation with complete Freund’s
adjuvant. The ¢nal mixture (200 Wl) containing silica and 50 Wg of
the puri¢ed GlcCer was then used to immunize 6 weeks old BALB/c
mice intraperitoneally. After 4 weeks, this procedure was repeated,
using incomplete Freund’s adjuvant. One week later, a last intraper-
itoneal injection was made, containing no adjuvant. 3 days before
fusion, the animals were boosted with an intrasplenic injection of 50
Wg of silica-adsorbed GlcCer.
Animals were killed and their spleens were removed and rinsed. For
cellular fusion, the myeloma mouse cell line Sp2/0 was then mixed in a
ratio of 1:5 with spleen cells. While gently shaking the cell mixture,
1 ml of a solution of polyethylene glycol (PEG 3000) was slowly
added drop by drop. The cell mixture was diluted in 10 ml of
RPMI-1640 medium, followed by settling for 15 min and centrifuga-
tion for 10 min (4‡C, 200Ug). The cells were resuspended in RPMI-
HAT medium supplemented with bovine fetal serum (10%) and plated
onto the wells of a £at-bottomed polystyrene microtiter plate. 10 days
after the fusion, hybridomas producing antibodies to GlcCer were
screened by enzyme-linked immunosorbent assay (ELISA) [11]. The
hybridoma culture whose supernatant had produced the highest level
of antibodies to GlcCer was expanded and cloned by limiting dilution,
over a feeder layer of macrophages, in a 96-well microtiter plate. The
feeder layer was obtained by washing the peritoneal cavity of non-
stimulated BALB/c mice with 3 ml of cold RPMI. Peritoneal cells
were resuspended in cold RPMI-HAT supplemented with bovine fetal
serum and distributed over microtiter plates (5U103 cells per well).
For preparation of antibodies in higher concentrations, antibody-pro-
ducing cells were injected into the peritoneal cavity of BALB/c mice.
Antibodies to GlcCer were puri¢ed by protein G a⁄nity chromatog-
raphy from ascitic £uids and isotyped as IgG2b using the Sigma ISO/2
kit.
2.7. Polyclonal antibodies to GlcCer
Polyclonal anti-GlcCer antibodies were obtained from serum of a
rabbit immunized with P. boydii, an opportunistic fungus that also
expresses cerebrosides similar to those described in this work [10].
Antibodies were puri¢ed by incubation of serum with immobilized
GlcCer followed by acid elution and immediate neutralization, as
previously described [10,11]. As expected, puri¢ed antibodies cross-
reacted with the puri¢ed GlcCer from C. gloeosporioides, as inferred
from ELISA and immuno£uorescence reactions (data not shown). To
exclude the possibility of unspeci¢c recognition of fungal structures by
antibodies to GlcCer, their reactivity with protein and lipid extracts
from fungal cells was also evaluated. As demonstrated by immuno-
staining and Western blot analyses, GlcCer from C. gloeosporioides
were the only structures recognized by puri¢ed antibodies (not
shown).
2.8. Immuno£uorescence
C. gloeosporioides conidia and mycelia were ¢xed in 4% parafor-
maldehyde cacodylate bu¡er (0.1 M, pH 7.2) for 1 h at room temper-
ature. Systems were rinsed in PBS and then in 1% bovine serum
albumin (BSA) in PBS for 1 h for further incubation with monoclonal
antibody to GlcCer (10 Wg/ml) and £uorescein isothiocyanate (FITC)-
labeled anti-mouse IgG (at 1:100 dilution). Control cells, which were
incubated with the £uorescein conjugate but not with antibodies to
GlcCer, were also prepared. Fluorescent reactions were observed in a
Zeiss epi£uorescence microscope (Axioplan 2).
2.9. Fungal di¡erentiation
106 conidia were suspended in 1 ml of a minimal medium (30 mM
glycerol, 10 mM MgSO4, 29.4 mM KH2PO4, 13 mM glycine, and
3 mM thiamine). This suspension was added to the wells of a 24-
well microtiter plate and supplemented with polyclonal or monoclonal
antibodies to GlcCer (25 Wg/ml). After 8, 12, 18 or 24 h of incubation
at 37‡C, glutaraldehyde was added to a ¢nal concentration of 2.5%.
Fungal di¡erentiation into mycelial forms was then assessed in an
inverted microscope. Control systems were performed identically, ex-
cept for the replacement of antibodies to GlcCer by irrelevant immu-
noglobulins (with no speci¢c a⁄nity for any fungal antigen) of the
same organism and isotype. All the systems were performed in tripli-
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cate sets and representative images of these experiments are shown in
Section 3.
3. Results
3.1. C. gloeosporioides expresses conserved GlcCer
The puri¢cation steps of GlcCer from C. gloeosporioides are
shown in Fig. 1. After extraction with mixtures of chloroform
and methanol followed by di¡erent steps of chromatographic
separation, an orcinol-reactive band was detected by HPTLC,
with a chromatographic mobility corresponding to a standard
GlcCer from bovine brain.
The GlcCer-enriched fraction was analyzed by positive ion
mode ESI-MS, showing a cluster of singly-charged ions with
m/z ranging from 700 to 860. Two major ion species were
observed at m/z 754 and 756, as well as their corresponding
fragments at m/z 736 and 738, generated after loss of water
(Fig. 2A). When submitted to ESI-MS/MS, these species gave
rise to major daughter ions at m/z 592 and 594, respectively,
162 mass units shorter than the parent ions, which most likely
corresponds to the loss of a hexose residue (Fig. 2B and D).
These daughter ions were tentatively assigned to the ceramide
moiety of the GlcCer species. Cleavage of the amide linkage
[23,24] is responsible for the low mass ion at m/z 294 and its
dehydration product at m/z 276, which are diagnostic of a C19
sphingadienine (Fig. 2C and E). The ceramide ion species at
m/z 594 and 592 could be assigned as N-2P-hydroxyoctadeca-
noyl-9-methyl-4,8-sphingadienine and N-2P-hydroxyoctadece-
noyl-9-methyl-4,8-sphingadienine, respectively.
The constituent monosaccharide was liberated by hydrolysis
and identi¢ed by TLC and GC-MS as glucose (not shown). In
the 1H-NMR spectrum of native GlcCer, protons correspond-
ing to a L-glucopyranosyl residue were recognized by their
characteristic chemical shifts (Figs. 3 and 4). The spectrum
displayed one sharp doublet at N 4.27 ppm with a coupling
constant (J1;2) of 7.85 Hz (Fig. 3), due to the protons bound
to anomeric carbon C-1. The remaining ring-bound protons
observed in the spectrum were in agreement with the L-gluco-
pyranoside structure. The long-chain base was consistent with
a 9-methyl-4,8-sphingadienine structure. A single vinyl reso-
nance (5.11 ppm) for the v8 unsaturation when C-9 is sub-
stituted with a methyl group (1.58 ppm) is characteristic of
cerebrosides from fungi [6,11,12] and some marine organisms
[25]. The resonance at 5.45 ppm was assigned as H-4 of the 9-
methyl-4,8-sphingadienine, characteristic of vinyl resonance
for the v4 unsaturation which is found in many glycosphin-
golipids present in fungi [4] as well as in mammals [26].
3.2. Immuno£uorescence
Polyclonal and monoclonal antibodies to GlcCer were pre-
pared and incubated with di¡erent forms of C. gloeospor-
ioides. The binding of these antibodies to the fungal surface
was then analyzed by £uorescence microscopy. As shown in
Fig. 5, mycelial forms of C. gloeosporioides were strongly re-
active with monoclonal antibodies to GlcCer. Surprisingly,
fungal septa were not recognized by antibodies. Conidial
forms also presented a di¡use pro¢le of reactivity with the
antibodies, but were less reactive than mycelia. The use of
polyclonal antibodies in these experiments produced similar
results (data not shown). Control cells, which were incubated
with the £uorescein conjugate but not with antibodies to
GlcCer, presented insigni¢cant £uorescent reactions (not
shown).
3.3. Antibodies to GlcCer inhibit the di¡erentiation of conidia
to mycelium in C. gloeosporioides
Several previous reports indicated the existence of a link
between cerebrosides in fungi and morphological transitions
or fungal growth [11,12,15^17,27]. In this context, we used
polyclonal and monoclonal antibodies to GlcCer as tools to
evaluate the relevance of glycosphingolipids as targets to in-
hibit the di¡erentiation of C. gloeosporioides. Conidia were
incubated in a chemically de¢ned medium supplemented
with antibodies to GlcCer and the process of di¡erentiation
into mycelia was evaluated after di¡erent intervals. In control
systems, which were performed in the absence of antibodies
(not shown) or in the presence of irrelevant immunoglobulins
(Fig. 6), conversion of conidia into mycelia was ¢rst detected
after 12 h of incubation at 37‡C (Fig. 6B). This morphological
transition progressively proceeded and reached a maximum
Fig. 1. Puri¢cation of GlcCer from C. gloeosporioides. Puri¢ed or partially puri¢ed fractions are visualized by reaction with orcinol-H2SO4 after
separation by HPTLC. For details of the steps of puri¢cation, see Section 2.
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intensity after 24 h. When the experiment was performed in
the presence of the anti-GlcCer monoclonal antibody, the
morphological transition of conidial forms into mycelia was
delayed; mycelial cells were detected only after 24 h of incu-
bation (Fig. 6E, F). Similar results were observed with poly-
clonal antibodies to GlcCer but, in this case, the inhibition of
di¡erentiation was even more e⁄cient, since no mycelial forms
of C. gloeosporioides were detected after 24 h of incubation
(Fig. 6I^L).
4. Discussion
Species from the genus Colletotrichum have been used for
many years in studies concerning fungal di¡erentiation and
fungal^plant interactions [2]. Colletotrichum species develop
a series of specialized infection structures including germ
tubes, appressoria, intracellular hyphae, and secondary ne-
crotrophic hyphae. Blocking the morphological transition
therefore appears to be an interesting alternative to prevent
the infection by the plant pathogen C. gloeosporioides.
In the present work, GlcCer were extracted from C. gloeo-
sporioides cells and characterized as N-2P-hydroxyoctadeca-
noyl-1-L-D-glucopyranosyl-9-methyl-4,8-sphingadienine and
N-2P-hydroxyoctadecenoyl-1-L-D-glucopyranosyl-9-methyl-4,8-
sphingadienine. Monoclonal antibodies against the GlcCer,
which is a very conserved structure in di¡erent fungal species,
were produced and used as the tools for the evaluation of the
role of GlcCer in the di¡erentiation of C. gloeosporioides. Our
results demonstrated for the ¢rst time that molecules recog-
nizing fungal cerebrosides interfere with the process of di¡er-
entiation of a plant pathogen.
GlcCer have been precisely characterized in a number of
fungal species [4^14]. For many years, these molecules were
thought to play exclusively structural roles in cell membranes
[28], but several results from recent reports argue against this
hypothesis [11,12,17,27]. Synthesis of GlcCer by fungi has
Fig. 2. ESI-MS (positive ion mode) analysis of the GlcCer species of C. gloeosporioides. A: MS1 spectrum. B^E: ESI-MS2 of the ion species
m/z 756, 738, 754 and 736, observed in A. Cer, ceramide; Hex, hexose; w, water.
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Fig. 3. 1H-NMR spectrum of GlcCer from C. gloeosporioides. Inset: Anomeric region (H-1) and coupling constant (J1;2 7.85 Hz).
Fig. 4. 1H chemical shifts (ppm) for the major GlcCer from C. gloeosporioides and its corresponding structure.
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emerged as an interesting target for the action of substances
with antifungal properties. For instance, Levery and cowork-
ers [17] reported on the block of germination and hyphal
growth of A. nidulans and A. fumigatus by D-threo-1-phenyl-
2-palmitoyl-3-pyrrolidinopropanol (P4) and D-threo-3P,4P-
ethylenedioxy-P4, two inhibitors of GlcCer synthase. This en-
zyme, which is encoded by GCS genes, catalyzes the ¢nal step
in the biosynthesis of GlcCer [29].
Binding of external ligands to GlcCer at the fungal surface
also results in the inhibition of fungal growth. In a very recent
study, Thevissen and coworkers [27] demonstrated that gcs
deletion mutants of both C. albicans and Pichia pastoris are
resistant against RsAFP2, an antifungal peptide isolated from
radish seed. These observations con¢rmed previous results
demonstrating that the replication of Saccharomyces cerevisi-
ae, which does not synthesize GlcCer, is not a¡ected by
RsAFP2 [27], which strongly suggests a role of GlcCer in
RsAFP2-mediated growth inhibition. Accordingly, GlcCer
were identi¢ed as the molecular targets for RsAFP2 [27]. In
addition, the interaction of RsAFP2 with fungal GlcCer was
found to be selective since RsAFP2 did not interact with
human or plant GlcCer nor with plant monogalactosyldiacyl-
glycerols. Similarly to RsAFP2, heliomicin, a defensin-like
peptide from the insect Heliothis virescens, is active on
C. albicans and P. pastoris parental strains, but displays no
activity on the gcs deletion mutants of both yeast species.
Furthermore, heliomicin interacts with GlcCer isolated from
P. pastoris and soybean but not with human GlcCer [27].
Antibodies to GlcCer have also been used to target glyco-
sphingolipids in fungal cells, producing inhibitory e¡ects
[10,11]. They were identi¢ed as inhibitors of the morpholog-
ical transition of P. boydii, although they did not in£uence
mycelial growth [10]. Di¡erentiation into mycelial forms is
also recognized as a crucial event in tissue invasion by
C. albicans [30], a fungus that synthesizes GlcCer [9]. As
with P. boydii, anti-GlcCer antibodies inhibited germ tube
formation in C. albicans [10]. In addition, they arrested the
growth of the human pathogen C. neoformans [11]. In these
reports, polyclonal antibodies were puri¢ed from sera of in-
fected individuals and added to experimental systems of fun-
gal growth or di¡erentiation. In the present work, we aimed
to evaluate the e¡ects of a GlcCer-binding structure on the
di¡erentiation of the plant pathogen C. gloeosporioides. In this
context, a monoclonal antibody to GlcCer was produced and
used as the GlcCer-binding tool in our experimental model.
From immuno£uorescence experiments using this antibody,
it can be concluded that the distribution of GlcCer in
C. gloeosporioides is di¡erent from those described in other
Fig. 5. Immuno£uorescence analysis of C. gloeosporioides mycelia
(A, B) and conidia (C, D) incubated with anti-GlcCer monoclonal
antibody. A and C show fungal cells under contrast phase microsco-
py, while £uorescent images are shown in B and D. Control cells,
which had not been incubated with antibodies to GlcCer, did not
present any signi¢cant £uorescent reaction (shown). Scale bar: 10
Wm.
Fig. 6. Antibodies to GlcCer inhibit the di¡erentiation of C. gloeosporioides conidia to mycelia. Conidial cells were incubated with control im-
munoglobulins (A^D), anti-GlcCer monoclonal antibody (E^H) or polyclonal antibodies to GlcCer (I^L) for varying periods. Formation of my-
celium was assessed in an inverted microscope.
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pathogens [10,11,31], in which this glycosphingolipid was
mainly accumulated into the sites of cell division. Points of
transport of presumed GlcCer-containing vesicles from the
plasma membrane to the cell wall were also suggested in other
species [11]. However, the reaction of C. gloeosporioides with
the anti-GlcCer monoclonal antibody revealed that, in this
plant pathogen, GlcCer is uniformly distributed over the fun-
gal surface. In agreement with a singular surface distribution
of GlcCer in C. gloeosporioides, fungal septa were not recog-
nized by antibodies. Conidial forms also presented a di¡use
pro¢le of reactivity with the antibodies, but were less reactive
than mycelia. The lower reactivity of the conidial surface with
antibodies to GlcCer could be explained by (i) a lesser expres-
sion of GlcCer at the cell wall of conidia, (ii) the expression of
structurally distinct surface GlcCer in conidial cells, or (iii) a
di¡erent wall assembly in conidia, in which conserved GlcCer
would be less accessible to antibodies. These hypotheses are
currently under investigation in our laboratory, through the
search of GlcCer in puri¢ed cell walls from C. gloeosporioides
mycelia and conidia. The isolation of GlcCer from C. gloeo-
sporioides cell walls will therefore allow the accomplishment of
quantitative tests followed by structural and immunological
analyses.
As described for P. boydii and C. albicans [10], polyclonal
anti-GlcCer antibodies puri¢ed from sera of infected individ-
uals inhibited the di¡erentiation of C. gloeosporioides with a
striking e⁄ciency. The monoclonal antibody was also e¡ec-
tive, although to a lesser extent. This could be explained by
the absence of highly inhibitory classes (or isotypes) of immu-
noglobulins putatively present only at the polyclonal prepara-
tion. In this regard, it is our intent to prepare additional
monoclonal antibodies to GlcCer of di¡erent classes, which
could present variable antifungal activity. Nevertheless, it is
now clear that external ligands recognizing GlcCer at the
fungal surface directly interfere with the morphological tran-
sition of human and plant pathogens. The identi¢cation of
selective probes with inhibitory activity against fungal patho-
gens may therefore reveal alternative strategies for the control
of human and plant infections caused by fungi. In this con-
text, experimental models to construct transgenic plants ex-
pressing antifungal polypeptides have been recently proposed.
For instance, transgenic Arabidopsis plants expressing a chi-
meric protein containing sequences of two di¡erent antimicro-
bial peptides, including the above-cited defensin RsAFP2,
were recently developed [32]. In this plant, the chimeric poly-
protein was found to be cleaved and the individual peptides
were functionally secreted into the extracellular space, show-
ing antifungal activity. In this regard, it would be also inter-
esting to identify the speci¢c sequences of antibodies to
GlcCer responsible for their antifungal action, which could
allow the development of alternative models of transgenic
plants less susceptible to fungal infections.
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